Finch Therapeutics Group, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LAKE STREET ADVISORS GROUP, LLC | 08/05/2024 | 21,206 | $29,052 | 0.00% | 1.32% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
VANGUARD GROUP INC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
MORGAN STANLEY | 10/17/2024 | 0 | $0 | -100.00% | 0.00% |
BLACKROCK INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
IKARIAN CAPITAL, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
BLEICHROEDER LP | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
Finch Therapeutics Group, Inc. institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of Finch Therapeutics Group, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 0
Avenir Management Company, LLC: 45,650
Amalgamated Financial Corp.: 942
FIRST MIDWEST BANK TRUST DIVISION: 0
1.32% of Finch Therapeutics Group, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 46,592 shares in the last 24 months. This purchase volume represents approximately $513,910 in transactions.